Literature DB >> 11177206

5,10-methylenetetrahydrofolate reductase common mutations, folate status and plasma homocysteine in healthy French adults of the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort.

A Chango1, G Potier De Courcy, F Boisson, J C Guilland, F Barbé, M O Perrin, J P Christidès, K Rabhi, M Pfister, P Galan, S Hercberg, J P Nicolas.   

Abstract

The 677cytosine mutation identified in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene has been frequently associated with an elevated plasma homocysteine concentration. The aim of the present study was to determine the impact of this MTHFR common mutation on plasma and erythrocyte folate (RCF) and plasma total homocysteine (tHcy) concentrations in healthy French adults. A cohort of 291 subjects living in the Paris area and participating in the Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) study were analysed to assess the impact of MTHFR polymorphism 677C-->T on folate status and plasma tHcy concentration. The frequency of the mutant homozygote for 677C-->T polymorphism (677TT genotype) in the present cohort was 16.8%. There were significant differences in plasma tHcy between 677CC, 677CT and 677TT genotype groups. The RCF concentrations were significantly different between each genotype, the lowest levels being associated with the 677TT genotype. When segregated by gender, no differences in tHcy between homozygous 677TT, heterozygous 677CT and wild-type 677CC genotype groups in women were observed. The fasting tHcy in women was unrelated to the 677C-->T mutation. However, tHcy was significantly increased in men with the homozygous 677TT genotype. We also analysed the possible implication of a second new MTHFR polymorphism (1298A-->C) in subjects with mild hyperhomocysteinaemia (4th quartile of homocysteinaemia; tHcy >11.1 micromol/l). The polymorphism 1298A-->C did not have a notable effect on tHcy or on the RCF levels. Our observations confirm a relatively high frequency of the 677TT genotype in the French population. Women with this genotype did not show the same increase in tHcy observed in men. In the present study dietary folate intake was not measured. Thus, the interaction of dietary folate with the MTHFR genotype in the French population needs further study.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11177206

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  11 in total

1.  Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults.

Authors:  Leslie A Lange; Damien C Croteau-Chonka; Amanda F Marvelle; Li Qin; Kyle J Gaulton; Christopher W Kuzawa; Thomas W McDade; Yunfei Wang; Yun Li; Shawn Levy; Judith B Borja; Ethan M Lange; Linda S Adair; Karen L Mohlke
Journal:  Hum Mol Genet       Date:  2010-02-13       Impact factor: 6.150

2.  Association of methylenetetrahydrofolate reductase (MTHFR 677C>T and 1298A>C) polymorphisms and haplotypes with silent brain infarction and homocysteine levels in a Korean population.

Authors:  In Bo Han; Ok Joon Kim; Jung Yong Ahn; Doyeun Oh; Sun Pyo Hong; Ryoong Huh; Sang Sup Chung; Nam Keun Kim
Journal:  Yonsei Med J       Date:  2010-02-12       Impact factor: 2.759

3.  Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis.

Authors:  Cornelia M Ulrich; Marian Neuhouser; Amy Y Liu; Alanna Boynton; Jesse F Gregory; Barry Shane; S Jill James; Michael C Reed; H Frederik Nijhout
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

Review 4.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

Review 5.  Potential Links between Impaired One-Carbon Metabolism Due to Polymorphisms, Inadequate B-Vitamin Status, and the Development of Alzheimer's Disease.

Authors:  Barbara Troesch; Peter Weber; M Hasan Mohajeri
Journal:  Nutrients       Date:  2016-12-10       Impact factor: 5.717

6.  Prevention of Neural Tube Defects in Europe: A Public Health Failure.

Authors:  Joan K Morris; Marie-Claude Addor; Elisa Ballardini; Ingeborg Barisic; Laia Barrachina-Bonet; Paula Braz; Clara Cavero-Carbonell; Elly Den Hond; Ester Garne; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Nathalie Lelong; Agnieszka Kinsner-Ovaskainen; Sonja Kiuru-Kuhlefelt; Kari Klungsoyr; Anna Latos-Bielenska; Elizabeth Limb; Mary T O'Mahony; Isabelle Perthus; Anna Pierini; Judith Rankin; Anke Rissmann; Florence Rouget; Gerardine Sayers; Antonin Sipek; Sarah Stevens; David Tucker; Christine Verellen-Dumoulin; Hermien E K de Walle; Diana Wellesley; Wladimir Wertelecki; Eva Bermejo-Sanchez
Journal:  Front Pediatr       Date:  2021-06-24       Impact factor: 3.418

7.  Preferential response of glutathione-related enzymes to folate-dependent changes in the redox state of rat liver.

Authors:  Aurélie Chanson; Edmond Rock; Jean-François Martin; Anne Liotard; Patrick Brachet
Journal:  Eur J Nutr       Date:  2007-04-26       Impact factor: 4.865

8.  The C677T methylenetetrahydrofolate reductase variant and third trimester obstetrical complications in women with unexplained elevations of maternal serum alpha-fetoprotein.

Authors:  Natalie K Björklund; Jane A Evans; Cheryl R Greenberg; Lorne E Seargeant; Carol E Schneider; Bernard N Chodirker
Journal:  Reprod Biol Endocrinol       Date:  2004-09-07       Impact factor: 5.211

9.  Association of homocysteine with type 2 diabetes: a meta-analysis implementing Mendelian randomization approach.

Authors:  Tao Huang; JingJing Ren; Jinyan Huang; Duo Li
Journal:  BMC Genomics       Date:  2013-12-10       Impact factor: 3.969

Review 10.  Biomarkers in autism.

Authors:  Andre A S Goldani; Susan R Downs; Felicia Widjaja; Brittany Lawton; Robert L Hendren
Journal:  Front Psychiatry       Date:  2014-08-12       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.